We are live on ! Find out more
MRT

MedEquities Realty Trust, Inc.
MRT

Delisted

MRT was delisted on the 16th of May, 2019.

97 hedge funds and large institutions have $314M invested in MedEquities Realty Trust, Inc. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

31% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 32

5% less capital invested

Capital invested by funds: $332M → $314M (-$18.2M)

6% less funds holding

Funds holding: 10397 (-6)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Holders
97
Holders Change
-6
Holders Change %
-5.83%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
7
Increased
42
Reduced
32
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
Assured Investment Management
New York
$27.2M
Goldman Sachs
2
Goldman Sachs
New York
$25.9M +$2.44M +229,679 +10%
Prudential Financial
3
Prudential Financial
New Jersey
$24.4M -$4.62M -434,800 -16%
American Century Companies
4
American Century Companies
Missouri
$22.1M -$65K -6,117 -0.3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$21.2M +$8.39M +789,901 +64%
Invesco
6
Invesco
Georgia
$15.2M +$1.16M +108,883 +8%
BlackRock
7
BlackRock
New York
$14.9M -$31K -2,915 -0.2%
N
8
Nuveen
North Carolina
$14.7M -$9.14M -860,285 -38%
Russell Investments Group
9
Russell Investments Group
United Kingdom
$12.2M +$1.21M +113,799 +11%
Boston Partners
10
Boston Partners
Massachusetts
$10.1M -$3.68M -346,630 -26%
ACB
11
Aristotle Capital Boston
Massachusetts
$10.1M +$2.44M +229,914 +31%
Charles Schwab
12
Charles Schwab
California
$7.99M -$182K -17,120 -2%
EBIM
13
Eagle Boston Investment Management
Massachusetts
$7.87M +$174K +16,363 +2%
State Street
14
State Street
Massachusetts
$6.92M +$1.03M +96,956 +17%
NIMC
15
NWQ Investment Management Company
California
$6.55M -$70K -6,592 -1%
Renaissance Technologies
16
Renaissance Technologies
New York
$6.49M +$1.89M +177,900 +40%
NC
17
Northpointe Capital
Michigan
$5.91M -$3.2M -301,081 -35%
SCM
18
Stadium Capital Management
Connecticut
$5.88M +$4.79M +451,315 +416%
SAM
19
Silvercrest Asset Management
New York
$4.75M +$171K +16,100 +4%
TCIM
20
TIAA CREF Investment Management
New York
$4.48M +$667K +62,745 +17%
PAM
21
Panagora Asset Management
Massachusetts
$4.06M +$1.76M +165,792 +75%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$3.87M +$201K +18,906 +5%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$3.73M +$129K +12,102 +4%
Northern Trust
24
Northern Trust
Illinois
$3.32M +$13K +1,223 +0.4%
SEI Investments
25
SEI Investments
Pennsylvania
$3.19M +$1.25M +117,397 +63%

MRT Hedge Fund Activity: Q1 2018 in Review

97 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in MedEquities Realty Trust, Inc. (MRT) for Q1 2018, worth a combined $314M — down 5.5% from $332M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MRT and 7 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 42 added.

The largest buyer was Vanguard Group, adding an estimated $8.39M. The largest seller was Nuveen, cutting an estimated $9.14M.

  • 97 institutional investors held MedEquities Realty Trust, Inc. (MRT) as of Q1 2018, down from 103 in Q4 2017.
  • Funds reported $314M of MedEquities Realty Trust, Inc. stock for Q1 2018, down 5.5% quarter-over-quarter.
  • 7 funds opened new MedEquities Realty Trust, Inc. positions in Q1 2018 and 12 closed out, a net change of -5 holders.
  • The largest MedEquities Realty Trust, Inc. buyer in Q1 2018 was Vanguard Group, an estimated $8.39M added.
  • The largest MedEquities Realty Trust, Inc. seller in Q1 2018 was Nuveen, an estimated $9.14M sold.

Based on aggregated 13F filings for Q1 2018.